Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MELODY Trial: Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease

NCT03850600 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT03850600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03850600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MELODY Trial: Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 30, 2019
Completion date
November 30, 2027
Enrollment
194 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, pregnancy